This is due to a change in carbohydrate metabolism, specifically an increased production of the pro-inflammatory acetate and a decreased production of butyrate, which strengthens the intestinal barrier and has anti-inflammatory effects (162)
In addition, treatment with the mitochondria-targeted antioxidant, mito-Tempo, significantly reduced cellular ROS levels
Some individuals experience strong reductions in cravings, while others see little effect
Cesarone MR, Belcaro G, Scipione C, et al
Liraglutide ( , Victoza , Saxenda), Dulaglutide( , Trulicity)
However, retatrutide may have superior benefits for insulin resistance and glycemic regulation , due to: Enhanced insulin sensitivity from GIP agonism Reduced hepatic glucose output from glucagon signaling modulation Improved beta-cell function Clinical Insight: Retatrutide reduced fasting glucose and A1C levels with similar or better efficacy than tirzepatide in early trials